The outlook of companies tied to Sildenafil's legacy presents a challenging investment picture . While the initial surge generated substantial returns , generic alternatives have significantly eroded https://adult900476.tusblogos.com/42449734/copyright-s-flagship-product-and-big-pharma-a-uncertain-investment